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INTRODUCTION 
The iron deficiency anemia found particularly in swine has 
a high incidence in the newborn. The nutrition of the sow inversely 
affects progression of the anemia. Newborn nutritional status, also, 
inversely augments the anemic condition. The anemia does not become 
apparent in the newborn until a few days following parturition. 
There is a drastic decrease in iron availab·ility with succeeding 
decreases in normal hemoglobin formation and mature red blood cell 
formation. An important factor along with these conditions is sus­
ceptibility to disease leading to death. A gradual return to normal 
follows if the newborn survives the anemic period. This condition is 
of economic significance to the swine producer for a variety of 
reasons. 
The newborn piglet faces initially a fast growing period with 
a small reserve of storage iron for the developing tissues. The 
stored �ron is quickly depleted and the anemia becomes apparent. The 
resulting erythropoietic malfunction may possibly be alleviated by 
prepartum maternal treatment and/or postpartum newborn treatment. 
Postpartum treatments may add additional stresses to the newborn 
enhancing the anemic condition. 
Enhanced hemoglobin precursor transfer to the fetus may be 
of primary importance in carrying the newborn past the critical 
1 
anemic period. The primary factor concerned with iron incorporation 
into the erythron and hemoglobin synthesis is the hormone, erythropoie­
tin. 
Several chemicals are being evaluated at the present time to 
provide an agent(s) that will successfully enhance hematological 
parameters of the newborn. A promising drug, dibenzyline, elicits 
serum iron level changes and increases peripheral blood flow. 
The purpose of this study was to investigate selected hemo­
gram parameters in pregnant rabbits and fetuses following prepartum 
treatments involving dibenzyline, injectable iron, and erythropoietin 
which may enhance hemogram parameters. 
2 
LITERATURE REVIEW 
Regulation of Ecythropoiesis 
Oxygen 
An important blood function is transporting oxygen to the 
tissue cells for metabolic processes. Hemoglobin, the conjugated 
protein, in the red blood cells is the primary means of oxygen trans­
portation. 
For some time it has been concluded that low oxygen partial 
pressure in the tissue cells elicits increased red blood cell pro­
duction (erythropoietic effect) by the bone marrow. Dreyer and 
Walker (
23) noted that at high altitudes where the oxygen tension 
was reduced there was an increase in the number of circulating eey­
throeytes. This has been substantiated by others.(SB, 119, 123) 
Numerous researchers have demonstrated that hyperoria and plethora 
3 
(by transfusion of erythrocytes) created a suppression of erythro­
poiesis· shown by a linear decrease in bone marrow activity.(13• 114, 
135) These observations have led many researchers to subject animals 
to hypoxia (reduced·atmospheric pressure) demonstrating subsequent in­
(5 6 29, 50, 124) creased red blood cell production. ' ' Grant and 
·Root, (59) however, could not demonstrate that regulation of erythro-
poiesis was directly dependent on the bone marrow oxygen concentration. 
Hormonal Control of Erythropoiesis 
- ( 14) Carnot and Deflandre developed the original hypothesis 
that direct bone marrow oxygenation was not the controlling factor, 
but a humoral factor was the important substance that was produced. 
4 
in a direct response to hypoxia and released outside the bone marrow 
into the circulating blood. This hypothesis was developed through 
injection of anemic rabbit serum into normal rabbits. There were very 
few investigations concerning this aspect for many years following 
their experiments. 
Within the last two decades many experiments have demonstrated 
a humoral factor in the blood. Reissman (1
12) showed corroborative 
evidence of the humeral factor utilizing parabiotic rats (artificial 
siamese twins) and subjecting one partner to chronic hypoxemia, the 
other to normal atmosphere. Significant evidence showed that the 
partial pressure of oxygen in bone marrow did not directly effect 
erythropoiesis. A hu.moral factor elicited by hypoxemia in one partne� 
was transfused to the other. · 
Attempting to locate the oxygen sensitive organ which elabor-
(131) ated the humoral factor, Stohlman et !!1_. demonstrated the factor 
as being produced inferior to the diaphragm in humans. Krumdieck (74) 
in an early experiment studied the effects of anemic animal serum 
injections on peripheral blood and bone marrow of normal recipient 
animals. Erslev (
24) demonstrated the plasma factor stimulated bone 
marrow activity because red blood cell production increased. 
The plasma factor was labeled hemopoietine by Carnot and 
Deflandre.<14) This was later changed to the more widely accepted 
erythropoietin by Bonsdorff and Jalavisto (a) because it was believed 
to control primarily red blood cell production. 
Erythropoietin Production 
Attempts to locate the site of erythropoietin production 
lia.ve led to excision of many organs and to organ extractions for 
the analysis of the hormone. Gordon has led the field in this early 
work. Gordon .tl &• (53) compared plasma, blood cells, liver, and 
5 
bone marrow from anemic rabbits to normal rabbits for erythro·poietic 
activity. Reticulocytosis, erythrocytosis, increases in hemoglobin, 
and packed cell volume were noted in extracts of blood cells, .liver, 
and plasma. Gordon et &_.(52) expanded his previous research using 
extracts of spleen, thymus, lung, brain, skin, pancreas, skeletal 
muscle, bone marrow, plasma, and packed blood cells of anemic -rabbits. 
When tested in normal rats, only plasma showed erythropoietic activity .• 
Jacobson et al. (66) and Erslev <25) demonstrated the liver did 
not produce erythropoietin, contrary to the results of Mirand ;!!,.!!;!. 
(94) and Lange and Gallagher. (?B) An increase in erythropoiesia .. failed 
to occ�� in rats exposed to reduced oxygen pressures when their livers 
were damaged with carbon tetrachloride.(94) Gordon(4
s) summarized 
the literature in that plasma or serum constituted the most concen­
trated source of erythropoietin in a hypoxic animal. 
Kidney 
Jacobson tl a1. <66) first suggested the kidney was the site of 
erythropoietic stimulating factor (erythropoietin) production. Bila­
teral nephrectomized rats and rabbits demonstrated no erythropoietie 
response to cobalt administration with increased levels of plasma 
eryth�opoietin. Bilateral nephrectomized dogs have also demonstrated 
abolished erythropoiesis, by decreased Fe59 incorporation into 
circulating red blood cells; almost total erythroid aplasia. (5a, 
97, 98) 
Naets (g
a) raised the question whether the decrease of iron 
incorporation was due to toxic product retention or actual absence 
of the renal factor. Nephrectomized animals showed lower erythro­
poietic rates, as measured by Fe
59 uptake, compared to ureter altered 
animals such as, ureter ligation in dogs and rats,(4
6
' 99) ureter 
section in rats, (gg) and ureterovenous anastomosis in dogs. (132) 
In p;rabiotic rats subjected to hypoxia, Fe59 incorporation 
6 
was less in nephrectom.ized partner than in the ureter ligated partner. 
( 116) 
,, 
Iron incorporation in the pairs where the nephrectomized part-
ner was hypoxic was greater than in those pairs where one was neph­
rectomized but neither hypoxic. This suggested other tissues than 
kidney contributed to the erythropoietic response. Gallagher et il• 
(41) favored ihis conclusion in rabbits when hypoxic nephrectomized 
rabbit ��asma extracts increased Fe59 incorporation 9. 5% in poly­
cythemic rats while normal plasma extracts and nonstimulated neph­
rectomized rabbit plasma extracts increased rat Fe59 incorporation 
5. 7% and 5.o% respectively. 
Nathan tl &• 
( 101) using four renaprival patients {hemoglobin 
conc. -7-9 gm./100 ml. ) showed an erythropoietic response to hypoxia 
in two patients and concluded there was other than a renal source of 
erythropoietin for red blood cell production. Abbrecht and Malvin(i) 
7 
and Hansen (
63) came to the same conclusion using hypoxic dogs and 
measuring differences in the titer of plasma erythropoietin between 
the renal artery and the renal vein by Fe59 uptake. They showed no 
difference between uptake. Possibly, the amount of erythropo1etin was 
so small that it could not be detected in the analysis. (2) 
Renal hypoxia initiated by the use of the Goldblatt clamp on 
the renal artery has afforded more of a ·- physiological situation for 
demonstrating erythropoietin titer differences. Noteworthy studies 
by Fisher and Samuels (
34) employed this method using varying degrees 
o.f constriction and showed an increase in plasma levels of erythro.. 
poietin at 12 hours up to a constriction of the artery at 57. 5"/, to 
71% of the preco�striction values. Takaku .tltl• (
134) employing both 
nephrectomized rats and unilateral renal artery constricted rats 
demonstrated the need for the kidney in increasing plasma erythro­
poietin levels following blood loss. 
Another major study avenue utilized was the isolated� vitro 
perfusion of the hypoxic kidney. Fisher and Birdwell,<
32) Kuratowska 
llil•, (77) and Zangheri tl al. (141) utilized the perfused kidney and 
observed erythropoietin in the renal vein blood. This was the most 
direct evidence that the kidney was the major, if not, the sole site 
of ery·thropoietin production. (77) 
Erslev ,tl a1.<2a) in a critical review of the 1B, vitro perfusion 
technique suggested the conclusion that erythropoietin was produced 
by the kidney in response to hypoxia was not justified. He used dog 
lung kidney preparations and showed no generation of the erythxopoietic 
8 
material after four hours of perfusion with normal, hypoxic, or anemic 
blood. He stated that erythropoietin was released only from injured 
and disintegrating tissue and not from metabolically active, well 
preserved kidneys, 
Pavlovic-Kentera tl�• (106) defined the situation further 
using perfused kidneys of dogs, In nine experiments only 5o% of the 
animals showed significant increases in- erythropoietin levels in the 
renal vein after five hours of perfusion, while all animals showed 
significant increases in erythropoietin titer after longer periods 
of time. 
The presence of high serum le�els of erythropoietin associated 
with erythrocytosis has been found in patients with renal neoplasms 
and cysts but this was indirect evidence of renal erythropoietin pro­
duction since nonrenal neoplasms are described with high erythropoietin 
serum levels. (14o) 
To further the importance of the kidney in erythropoietin 
production a quantitative assay measure of erythropoietin activity 
needs to be developed. (3, 
126) This may prove that erythropoietin is 
physiological in emergencies but under normal conditions is involved 
ma.inly in fine red blood cell adjustments. 
Nature .Qf. Erythropoietic Factor 
It has been suggested for a decade that tl-10 humeral factors 
regulated control of erythropoiesis. One, being heat stable and ether 
soluble which stimulated cellular division in erythroblasts. The other 
being heat labile and ether insoluble which augmented hemoglobin 
9 
synthesis. (
82) 
Kuratowska. tl&•(?G) elaborated on several theories to explain 
the two factors. The renal factor has been demonstrated in the per­
fusate of the isolated kidney. Incubation of it with plasma {required 
alpha globulin) yielded an erythropoietically active substance.(
15• 43) 
The theories debated are as follows: 1) The renal factor, REF (renal 
erythropoietic factor), may be a precursor of erythropoietin and be 
activated by a system in the alpha globulin portion of blood. {76) 
2) The renal factor may act as an enzyme, and activate a precursor 
in the alpha globulins to yield erythropoietin. (49, 7o, 142) 
Stohlinan. (128) noted the similarities of this mechanism with the renin­
angiotensin complex. 3) The renal factor may combine with a portion_ 
of the alpha globulin to heat stabilize and activate it. (1
5
• 49, 75) 
Study of the above theories was complicated by the rapid turn­
over rate of erythropoietin, possibly due to accumulation of an inhi­
bitor.<113) Dalos et &_.(19) using X-ray irradiation of rabbit spleen 
isolated a factor that decreased heme synthesis in red blood cells. 
Kuratowska (75) theorized an erythropoietin stimulator and inhibitor 
that controled the erythropoietic system. 
Kidney Production Site .2£ Erythropoietin 
Osnes (1o5) suggested the renal cortex, mainly the juxtaglomer­
ular apparatus, as the site of erythropoietin production. AbbTecht 
tl-�.(2) and Muirhead et &•(97) noted significantly higher 1..evels of 
erythropoietin released from the renal cortex than other areas. The 
juxtaglomeru.lar cell under anemic and high altitude conditions have 
greater secretory granules and elaborate large amounts of erythro­
. t· (
21, 64) poie in. 
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Tobian (13
6) noted the relationship between the abundanc7 of 
granules in the ju.xtaglomerular cells and the arterial pressure to­
gether with electrolyte concentrations. an inverse relationship. This 
granularity was correlated with large quantities of extractable renin. 
Renin and erythropoietin were demonstrated to be separate sub­
stances. (
2) Goldfarb and Tobian (44) in hypoxic and hyperoxic ex­
periments showed no change in ju.xtag1omeru1ar cell granularity after 
an extended period of time. They conc1uded hypovolemia rather than 
hypoxia elicited the response in cell granularity. 
Baum tl &• (7) and Fisher tl tl• (35) using rabbit anti-sheep 
erythropoietin antibodies, found the glomerular tuft as the site of 
erythropoietin elaboration in anemic sheep kidneys with no staining 
in the ju.xtaglomerular area or in the spleen, lymph nodes, or liver. 
Wesson (14o) stated that no more than indirect evidence has been 
offered to establish the cellular source of renal erythropoietin. 
Properties of Erythropoietin 
There existed many conflicting viewpoints on the chemical and 
physical nature of erythropoietin. The following list was complied 
from various literature. 
1. Erythropoietin was stable to heat at pH 5.5-9.0, and des­
troyed at pH 1 or 13. (s
1, 111' 122) 
(45) 
2 •. Resisted breakdown at 100
° 
C. temperature for a few minutes. 
3. Digested by pepsin, chymotrypsin, trypsin, (
54, 122) 
and 
11 
sialidase. (45
, 76) 
4. Using 200 fold purification of erythropoietin by Dowex 50 
chromatography, erythropoietin was found to be a glycoprotein-36% 
protein, 15% carbohydrate, 3.7% sialic acid, and 1.1% hexosamine.(45
, 76) 
5. Continuous flow electrophoresis has shown it to migrate as 
an alpha-2-globulin. (1
11) 
6. Erthropoietin has a probabl9 molecular weight between 
60,000 and 70,000, (45) while a molecular weight of 27,000 has been 
observed. <115) 
� .2f. Action of Erythropoietin 
by the 
oxygen 
Erythropoietin levels in the plasma are primarily influenced 
state of'the erythroid tissue <
125) and relationship between 
supply and demand.(39, 1
25) When oxygen demand became severe 
the response to erythropoietin was limited primarily by the oxygen 
requirement for oxidative metabolism in red blood cell precursors, 
which was necessary for maximum response to erythropoietin.(129) 
Early work by Krumdieck(74) utilizing rabbits demonstrated 
significru1t changes in circulatory reticulocytes three days post­
injection of anemic serum but no changes in circulation red b1ood 
cells or hemoglobin at that time. Filmanowicz and Gurney (3
o) noted 
in mice following ad.ministration of erythropoietin that after three 
days peripheral reticulocytosis appeared. The wave of erythropoiesis 
also showed at 24 hours a peak in proerythroblasts and at 72 hours a 
peak in normoblasts. Re concluded that the stem cell was the site of 
action for erythropoietin. Later observations were consistent with 
erythropoietin action being directed toward differentiation of stem 
cells. (27, 140) Using rabbit a.ntihu.man erythropoietin antibodies 
in mice with tritiated thymidine (detect increase in mitotic acti­
vity), Schooley and Garcia (
120) observed an erythropoietin effect 
on differentiation of stem cells with no effect on maturation of 
erythroid cells. Conversely, Gallagher et _tl. (4
2) concluded that 
erythropoietin exerted its effect on di:fferentiation of eryth.roid 
cells into mature erythrocytes. Borsook et &•(g) found, measuring 
c14 incorporation into hemoglobin, when an erythropoietic crisis was 
present cells by pass the orthochromatic erythroblast stage in 
maturation to shorten the maturation time. 
12 
Stohlman (127) supported a single mode of action involving 
changes in differentiation rates of stem cells and/or erythroid cells. 
by erythropoietin. This theory involved erythropoietin interaction 
with an unknown enzyme to form a. product capable of' initiation of 
hemoglobin synthesis. - Others shared sicilar conclusions in support­
ing erythropoietin enha.ncement·or hemoglobin synthesis in differen­
tiated ecythroid cells.<73) Stohlman �tl•(13o) defined an inter­
mediate precursor cell, a more differentiated stem cell, as being 
affected by erythropoietin. 
Recent research suggested erythropoietin activation of stem 
cells was closely associated with DNA synthesis. (
1o
4
) Krantz and 
Goldwa�ser (72) demonstrated an activation of messenger RNA by erythro­
poiet.in which caused an initiation of the metabolic chain reaction 
leading to formation of mature red blood cells. 
13 
Other Factors Influencing Erythropoiesis 
The presence of an extrarenal erythropoietic factor has been 
observed by researchers. Bilateral nerhrectomy in rabbits (26, 3a) 
and excision of the kidneys in rats (93) demonstrated the preservation 
of some erythropoietic activity. Antiserum of rat renal erythropoie­
tin neutralized the plasma erythropoietic factor elaborated in neph­
rectomized animals. (3s) The search for an extrarenal erythropoietin 
source lead researchers to different organs. 
Central Nervous System 
The central nervous system (CNS) has been studied for its 
effect on erythropoiesis. The hypothalamus was indicated as exer­
ting a regulatory' function (1
21 ) while the caudate nucleus , hippo­
campus, and cerebrum had no function. (a7) 
El.ectrical stimulation of the hypothalamus in rabbits , ( 1 21) and 
monkeys(9
2 ) augmented arythropoiesis by increasing Fe59 incorporation 
into erythrocytes and reticulocytes, and increasing blood volume. Con­
versely, ·Piliero ll il• ( 
109 ) in rats and Mirand tl &• ( 92) in monkeys 
with hypothalamic lesions found no change in the erythropoietic :.· 
response. 
Mirand (
ag ) postulated the effect was due to a nervous pathway 
and/or hormone on the erythropoietin �roducing organ(s ). Medado !i 
.s1,. <s
7) further proposed the autonomic nervous system (ANS) . pathvay to 
the bone marrow as the means of action. He demonstrated this by 
suppression 0£ the erythropoietic effect following atropine adllD.Ilis­
tration prior to stimulation. Halvorsen et !l!_. (
62) suggested an 
2 6 5 6 0 3  
effect through the pituitary gland release of hormones  and/or ANS 
on blood flow in erythropoietin producing organs or bone marrov. 
Endocrine 
1 4  
Hypophysectomy reduced erythropoiesis greatly within one to 
three weeks in rats, but the ability to produce erythropoietin was 
still present . ( G7) The role of the pituitary as a primary effector 
of erythropoiesis has been refuted . (4o , -61 • 
1 07) Crafts and Meineke 
( 1 G ) suggested a secondary role of the pituitary in erythropoiesis 
through thyrotrophic hormone, adrenocorticotrophic hormone and growth 
hormone effects on general metabolic changes leading to decreased 
oxygen demand and eventually decreased e:cythropoiesis. 
Testosterone administration has stimulated erythropoiesis in 
polycythemic mice . (3G) Several investigators suggested testosterone 
promoted erythropoiesis by stimulating the elaboration of erythropoie­
tin. Fried and Gurney ( 37) stated that kidney growth was stimulated by 
testosterone ; especially epitheleal cell cytoplasm. Conversely, 
Meineke �d Crafts (B8 ) suggested that testosterone acted synergis­
tically with hypoxia or erythropoietin to exert its erythropoietic 
effects. Mirand et _&. (9 1 ) supported synergism between hypoxia and 
androgens in activating adrenocorticotrophic hormone release leading 
to increased corticosteroid release. Naets and Wittek( 1 00 ) presented 
evidence supporting the concept that testosterone potentiated the 
action of erythropoietin by either increasing stem cell sensitivfty to 
erythropoietin or increasing actual numbers of stem cells. 
Estrogen i.nhibited erythropoiesis probably by suppressed pro-
1 5  
duction or activity of an extrarenal precur�or erythropoietin. ( 55 , go) 
During prolonged administration of a massive dose of estrogen in rats 
erythropoietin production uas depressed and iron utilization was 
impaired because it was fixed in iron laden cells. { 1 os) Gordon tl &• 
( 5 1 ) supported direct action of estrogen on erythropoietic tissue to 
diminish the number or response of stem cells to erythropoietin. 
Conversely , Jepson and Lowenstein ( 69) noting high plasma estrogen -
levels and correspondingly high erythropoietic activity in pregnant 
mice suggested inhibition of Fe59 incorporation into stem cells but 
not later erythroid cells. 
Cobalt 
Cobalt , a 'metal capable of stimulating erythropoiesis, has its � .  
major effect on erythropoietin producticn. (47) The inactivation 0£ 
sheep erythropoietin in rat kidney homogenates has been prevented by 
adding high concentrations of cobalt. (
33) Erythropoietin recovery 
was greater in the cobalt homogenates than in the non cobalt homo­
genates. This lead to the theory of cobalt acting as an antagonist to 
a renal erythropoietic inhibitory factor. 
Kuratowska ( 75 ) noted the effects of CNS (hypothalamus) � 
hormones (androgens , growth hormone , and others ) , oxygen supply, red 
blood cell mass , and other factors (cobalt ) ·on the production or ery­
thropoietin by the kidney. He stated 1 o%  of the erythropoietie factor 
Was produced extrarenally in normal humans. 
Fetal Erythropoiesis 
Transfer and Uptake of Iron by the Fetus 
1 6  
Through the use of Fe59 the plasma has been found to be the 
important source of fetal iron , not red blood cell hemoglobin , ( 1 1 0 ,  
1 38 ) Morgan ( 95 ) demonstrated in pregnant rats and rabbits a decrease 
in hemoglobin and plasma iron towards parturition with an increase in 
fetal utilization of iron. A marked increase in radioiron uptake by 
the placenta and fetus with advancing gestation , with a sharp increase 
during the last trimester , has been found in rabbits ( 2o ) and swine , (
6S )  
Hoskins and Hansard ( 6 S ) in sheep noted three stages o� fetal 
hemopoiesis ; in liver and spleen early in fetal life , in red bone 
marrow in the second trimester , and equally in all tis�"Ues in the last 
trimester. Incorporation into developing tissue seemed to have the 
greatest influence on transfer rate of iron� Also . implicated 1n.-. 
the regulation of iron transfer were the general state of maternal 
iron metabolism and the iron supply in the maternal plasma, ( 1o
) 
Placental transfer of iron occurred against a concentration gradient 
with uptake by the placenta being an active process while retrograde 
transfer ·back to maternal tissue did not occur , ( 1 o) 
Ferritin-Transferin Transport Mechanism 
Granick( S6 ) demonstrated the presence of ferritin in the in­
testinal mucosa of guinea pigs . By feeding iron to these animals 
he noted an increase in the concentration of apoferritin ,  appearing 
in the form of ferritin, which regulated the absorption of iron. 
Rush tl &, (
1 1 7 ) proposed when ferritin was present in high concen­
tration in the mucosal cells active transport of iron was inhibited 
through the cells .  This mechanism is the subject of lively disputes . 
In iron deficiency situations a lack of ferritin in the mucosal cells 
allowed free passage of dietary iron into the cells and thence into 
the body. ( 17 ) Late in pregnancy iron transport across the gut in­
creased with in vitro gut sacs and .!!!, � duodenal loops. - _ 
A two-step mechanism for iron absorption has been suggested. 
( 1 2, 1 8, 84 ) First, rapid mucosal uptake of iron occurred in a non-
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protein iron form. Following this ferritin (protein-bound iron) for­
mation occurred in the cell. Second, slow serosal transfer of iron to 
the blood, a rate limiting step, remained constant and maxima1. This 
second step was more dependent on oxidative metabolism. 
Nylander ( 1 o3 ) observed the presence of ferritin in the allan­
toic placenta of normal rats but in the anemic group little ferrltin 
was found. Fineb�rg and Greenberg ( 3 1 ) measured the incorporation of - , ,  
c14 from labeled amino acids into liver ferritin and demonstrated that 
administered iron accelerated de n2Y.Q. synthesis of the protein por-
tion of ferritin. Granick ( S? ) reviewed this theory stating an in­
crease in apoferritin, generally parallels an increase in iron. 
Transf errin , plasma iron-binding protein, bound by the pla­
centa released its iron to rat placental tissue. (79 • OO) Larkin tl 
&. (79 ) demonstrated in pregnant rabbits a release 0£ iron from 
transferrin to the maternal circulation. 
Transferrin from maternal serum transfered to fetal serum in rats 
and rabbits while some was bound to placental tissues. (9
6 ) Masters 
et al (a5 ) --· 
in rats. 
also demonstrated transferrin transmission to the fetus 
Transfe·r was low until the last three days of gestation 
When it increased rapidly. 
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Transfer of Erythropoietin 
Jacobson and associates ( 68 ) , using hypertransfusion in preg­
nant rats, suppressed maternal but not fetal erythropoiesis . They 
concluded that fetal erythropoiesis operated independent of maternal 
erythropoiesis. They offered two theories : 1 )  the fetus produced 
erythropoietin , therefore erythropoietin did not cross the placenta to 
maternal tissue , or 2 ) fetal erythropoiesis operated independently of 
the erythropoietic mechanism. In favor of the latter theory was that 
erythropoiesis developed before the functionally intact kidney . Zanjani 
tl &• ( 1 43 ) found fetal erythropoietin production induced by hypoxia 
with the amount of erythropoietin being proportional to the intensity 
of the anemia and no maternal erythropoietin influencing the fetus.  
Iron Relationships 
McGowan and Crichton (86 ) first diagnosed nutritional iron 
deficiency anemia in suckling pigs . Since that time administration of 
various chemicals in combination with iron have been utilized to 
remedy this condition. 
Iron dextran given du.ring the suckling period in baby pigs 
has proven successful in maintaining normal hemoglobin values. ( 1 37 ,  1 4
4)  
Also, iron dextran given tw·o weeks prepartum to  the sow maintained 
high hemoglobin levels during the critical postpartum period in the 
newb · t · · 1 d. · ·t · d • . ( 
1 39 ) � orn. Other prepara ions , me u ing pep onize iron, ierric 
anunoniu.m citrat� , <22 ) ferric phosphate , and iron copper paste have pro­
duced generally inferior results. 
Synergistic roles of iron with various compounds have been 
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utilized to enhance placenta transfer of iron with resulting allevia­
tion of the neonatal anemia . Swanson ( 1 33 ) investigated partial pro­
tein-free filtrate ( PPFF) , iron dextran , and B vitamin effects. in 
swine. Prepartum sow and postpartum piglet treatment were compared 
to saline controls . Hemogram parameters showed iron dextran post­
partum alleviated the neonatal pig anemia . Combined PPFF . {erythro­
poietin) · and iron dextran prepartum and. postpartum. produced an. 
erythron response . PPFF seemed to be synergistic in placenta1 transfer 
of iron . All other combinations showed little or no significant 
hemogram changes . Ulbrey tl &• ( 1 37 ) administered iron dextran and B 
vitamins postpartum to piglets and found no hematological improve-
ment over controls . 
Lippert (a3 )  investigated the synergistic effects of iron dex-
tran , rabbit PPFF , and vitamin C administered prepartum in rabbits. 
He found no enhanced transfer of iron or erythropoietin to the fetus . 
Dibenzyline (N-pheno3
isopropyl-N-benzyl-.@.-chloroethylamine hydro­
chlorid§t 
Schade tl .tl• ( 1 1 8 ) administered phenoxybenzamine (diber...zyline) 
to rats prior to oral dosage of Fe59 • He demonstrated increased serum 
iron levels and increased plasma iron clearance following adroini �tra­
tion .  
Dibenzyline is a representative type of an alpha adrenergic 
blocking agent . Dibenzyline has a slow onset of action even after 
IV · administration, due to the time required for formation of reactive 
intermediates . < 1 02 )  The methyl side chain group increased absorb­
ability in the intestinal mucosa. 
Pharmacologically dibenzyline produced longer acting blockage 
than any other adrenergic blocker. < 71) Cardiovascular effects are 
varied in normotensive individuals including increased cardiac ' output, 
decreased total peripheral resistance, and induced fall in blood 
pressure. 
Dibenzyline was first used clinically in 1 950. (GO) Dibenzyline 
was effectively administered by all routes. It has a high solubility 
at body pH with accumulation in fat at large doses. Agarwal and 
Harvey (4) noted prolonged action due to slow release from a receptor 
substance in the tissue. Brodie tl &• <11 )  observed metabolization 
of dibenzyline by dealkyation to the corresponding amine then excre­
tion by the kidneys. 
MATERIALS AND METHODS 
Experimental Animals 
Twenty-four Dutch Belted virgin doe rabbits weighing between 
1500 and 1900 grams were utilized £or this investigation. A11 
rabbits were examined initially and found to be alert , active . and 
apparently in good health. Experimental animals were individually 
caged in stainless steel batteries and maintained on a commercial 
rabbit pelletized diet1 and water !S!_ libitum. 
Genera� Procedures 
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Animals were adapted for 10 days to the experimental environ­
ment. A table of random numbers was used to separate the does into 
experimental and control groups, each containing three animals. Does 
were mated to Dutch Belted males twice on the same day. 
Pretreatment blood samples of 5 ml. were taken via cardiac 
puncture on day 25 of gestation using aseptic techniques and employ­
ing sodi'l.Pil heparin as an anticoagulant. Cardiac puncture preparation 
of the una.nesthetized rabbits involved thoracic shaving and applying 
Zephiran Chloride diluted 1 :750 topically. 
Doe treatments were administered on day 25 of gestation as 
follows : 
Group I ... - - saline controls ( C) 
Group II  - iron dextran (Fe) 
1
Rabbit Chow , Ralston Purina Company, Checkerboard Square, 
St. Louis, Missouri 63188. 
Group III - erythropoietin (Ep) 
Group IV - dibenzyline ( D) 
Group V - iron dextran and erythropoietin (Fe+Ep) 
Group VI - dibenzyline and erythropoietin (D+Ep)  
Group VII - iron dextran and dibenzyline (Fe+D) 
Group VIII - iron dextran, dibenzyline, and erythropoietin 
(Fe+D+Ep) 
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Treatments were as follows for the different groups : three ml. 
of saline were administered int�peritoneally to � -control. -animal:,;  
fifty mg./kg. of iron dextran
2 
were administered intramuscularly; two 
units/kg. of erythropoietin3 and saline were administered intraperi­
toneally; and twelve mg. /kg. of dibenzyline4 and saline were given 
intraperitoneally. I 
Posttreatment doe blood samples were taken on day 30 of gesta­
tion via cardiac puncture in the same manner as pretreatment samples. 
Does were sacrificed on day 30 by inducing air embolism and the fetuses 
were removed by cesarean section. The fetuses were decapitated and 
adequate blood samples taken for duplicate red blood cell counts , 
packed cell volumes , and hemoglobin determinations. 
Analytical Procedures 
2
Pigdex Iron-Dextran Injection, Agricultural Division, 
American Cyanamid Company , Princeton, New Jersey 08540. 
3connaught Hedical Research Laboratories , University of 
Toronto, Willowdale, Ontario Canada . 
4smith, Kline and French Laboratories, Philadelphia, Pennsylvania 1 9101 . 
Red Blood Cell Count 
Red blood cell cowits were obtained employing a Coulter 
Counter Model F . 5 The counter was standardized for rabbit red 
23 
blood cells with the attenuation set at . 707, aperture at 1 6 ,  and 
threshold at 7 . The dilution of 1 to 50, 000 was accomplished by a 
two step method . First, 40 lambda of blood was added to 20 ml . of 
normal saline (0. 9o% sodium chloride and 0. 1%  sodium azide ) utilizing 
a Coulter Counter Dual-Diluter . 6 Second, 200 lambda of the above 
solution was added to 20 ml.  normal saline. The counts were per­
formed in duplicates . The background counts on the saline solution 
were performed and considered insignificant if less than 200. The 
red blood cell count found was corrected with the Coulter Counter 
Coincidence Correction Chart7 for two or· more cells passing through 
the aperture at the same time .  
Hemoglobin Concentration 
Duplicate hemoglobin values were obtained by using the cyan­
methemoglobin technique .
8 
A Hycel Cuvette Chemistry System9 was 
calibrated to deliver the appropriate amounts of HycelR reagent 
Texas 
5coulter Electronics , Inc . ,  Hialeah, Florida 3301 0 .  
6Ibid. 
7Ibid . 
8
Hycel Cyanmethemoglobin Determinations , Hycel, Inc . ,  Houston, 
77036 . 
9Hycel, In
c
. }  Houston , Texas 77036 . 
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(6 . 0  ml . ) .  A sample volume of 0 . 02 ml .  of blood was removed and added ' 
to the 6 . 0  ml . of reaL;ent . This solution l'Tas read against a reagent 
blank at 540 millimicrons on a Coleman Junior II Spectrophotometer 
Model 6L2o.
1 0  Readings were transferred to a standard curve and 
totai hemoglobin concentration in gm./1 00 ml . obtained directly. 
Packed Cell Volume 
Packed cell volumes ( PCV). ·were determined employing _the micro­
hematocrit method. 1 1 Duplicate blood samples were introduced into 
heparinized microhematocri t capillary tubes. The tubes w-ere centri�-: ... ..; 
fuged for five minutes at 1 2 , 500 rpm in an Adams Micro-Hematocrit 
Centrifuge . 1 2 Values were obtained employing the Adams I�1icro-Hemato­
cri t Tube Reader '( Chart Type ) .  
1 3  
The mean corpuscular volume (MCV) , mean corpuscular hemoglobin 
(MCH), and mean corpuscular hemoglobin concentration (MCHC) were 
calculated from the following formulas : 
MCV (cu. ) = ____]2§.cked cell volume x 1 0  
erythrocytes , millions/cmm. 
MCH (uug. ) = hemo lobin concentration . 1 00 ml . blood x 10 
erythrocytes , millions cmm. 
MCHC (%) = hemoglobin concentration, gm./1 00 ml . blood x 1 00  
packed cell volume 
York, 
1 0  
Coleman Instruments , Haywood , Illinois 601 53. 
1 1  
Adams J.Iicro-Hematocri t Technique, Clay-Adams t Inc . , llew 
New York 1 001 0.  
1 2 Clay-Adams, Inc. ,  New York, New York 1001 0 .  
1 3Ibid. -
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RESULTS 
Individual hemogram values of does receiving prepartu.m treat­
ments along with control animals are listed in the appendix in tables 
5 through 12. Three does died during cardiac puncture and three does 
were non gravid. Mean pre and posttreatment doe hemogram values are 
listed in tables 1 and 2, respectively. Overall mean pretreatment 
6 hemogram values for the 23 experimental does were : 4. 91 x 10 
erythrocytes/cmm. ; 1 1. 4  gm. hemoglobin/100 ml. whole blood; 34. 4% 
packed cell volume; 71 . 3  cµ. , MCV; 23. 5 µµg. , MCH; and 33. 1 %, MCHC. 
Individual doe hemogram values changed within groups although 
the amowit of c�ge was not significant in an analysis of variance. 
However, a lack of significance possibly should be expected because 
of the number of does used and doe to doe variability. Certain does 
showed notable trends . Does 2 and 3 in the iron dextran treated 
group demonstrated increased RBC count, Rb, and PCV with correspond­
ing decreases in MCH values . Doe 3 had increases of about 12o% for 
RBC count, about Bo% for Hb concentration, and about a 2o% decrease 
in MCH. Combining erythropoietin and iron dextran elicited increased 
RBC, Hb, and PCV values for all three does. Doe 3 values in the 
d.ibenzyline treated group decreased notably; about 3a/o for RBC count 
and 2o% for Hb, while the MCH value increased. Iron dextran and 
dibenzyline treated does demonstrated increased RBC counts along with 
· decreased MCV values. Treatment with a combination of erythropoietin, 
iron dextran, and dibenzyline decreased doe Hb values. 
Mean doe values for treated groups changed notable following 
treatment with the three compounds. Dicenzyline administration in 
group IV decreased all parameter values during the treatment period, 
especially the RBC count, Hb, and PCV about 15%, 2a/,, and 16. �, 
respectively . Erythropoietin and iron administration increased RBC 
count, Hb, and PCV by about 25%,  14 . 6%,  and 22% respectively. 
Analysis of variance results on fetal data are summarized in 
table 4. Significant changes are noted �n the table. 
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Mean fetal rabbit hemogram values are recorded in table 3 , 
while individual values are listed in tables 5 through 12. Compar­
ing mean fetal hemogram values of the experimental animals to the 
controls indicated dibenzyline treatment caused the greatest increase 
in RBC, llb, rev, and MCV values. Group VIII had the largest increase 
in the MCH and MCHC values over controls. Groups VIII and VI elicit­
ed similar responses as group IV in the MCV and MCH values . Combina­
tion treatments of dibenzyline and erythropoietin decreased RBC, Hb, 
- and PCV values over controls; the only treatment that showed this 
alteration , though this group had high MCV and MCH values. Weight 
_increases by each group over control fetuses were noted. 
Table 1 :  Average Pretreatment Doe Rabbit Interactions of Iron Dextran , 
Dibenzyline , and Erythropoietin, 
Source 
( treatment ) 
No D ,  Ep , or Fe 
D 
Ep 
D+Ep 
Fe 
D+Fe 
Ep+Fe 
D+Ep+Fe 
6RBC 
Hb 
( 1 0  /cmm. )  (gm./1 00 ml . )  
5 . 20 1 2 . 30 
5 . 32 1 2 . 33 
4 , 25 1 0 . 73 
5 , 38 1 1 , 73 
4 , 74 1 0 . 87 
5 , 04 1 1 . 90 
3 , 93 9 , 57 
5 , 42 1 1 , 70 
PCV 
(%) 
38 . 1 5  
36 . 87 
32 . 1 7  
35 , 30 
32 . 27 
36 . 33 
27 . 67 
36 , 83 
MCV 
( cµ. )  
73 , 44 
69 . 23 
78. 93 
65 . 69 
72 . 5 1 
. 72 . 24 
70 . 55 
68. 07 
MCH 
(µµg. ) 
23 . 66 
23 . 1 6 
25 , 45 
2 1 . 88 
24 . 1 2  
23 . 67 
24 , 78 
21 , 49 
MCHC 
(%) 
32 . 26 
33 . 4 5 
33 . 33 
33 . 27 
33 . 27 
32 . 70 
35 , 23 
3 1 , 59 
I\) 
� 
Table 2 :  Average Posttreatment Doe Rabbit Interactions of Iron Dextran , 
Dibenzyline , and Erythropoietin . 
Source 
( treatment ) 
No D ,  Ep , or Fe 
D 
Ep 
DtEp 
Fe 
DtFe 
Ep+Fe 
D+Ep+Fe 
6RBC Hb 
( 1 0 /cmm. ) (gm./1 00 ml . )  
5 . 34 1 1 . 55 
4 . 54 9 . 70 
5 . 03 1 0 . 63 
5 . 36 1 0 . 93 
5 . 08 1 1 . 70 
5 . 9 1 1 1 . 87 
4 . 90 1 0 . 97 
5 ,82 1 2 . 00  
PCV 
(%) 
35 . 00 
30 . 75 
34 . 00 
34 , 83 
35 . 50 
33 . 83 
33 . 83 
37 . 25 
MCV 
(cµ. ) 
66 . 20 
68. 39 
67 . 80 
64 . 95 
70 . 25 
57 . 1 4  
69 . 30 
64 . 34 
MCH 
(µµg. ) 
2 1 . 92 
2 1 . 85 
2 1 . 1 7  
20 . 38 
23 . 1 2  
20 . 1 6  
22 . 47 
20 . 70 
MCHC 
(%) . 
33 . 09 
3 1 . 88 
3 1 . 23 
31 . 37 
32 . 86 
36 . 59 
32 . 46 
32 . 1 9  
I\) 
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Table 3 :  Fetal Average Main Effects and Interactions of Iron Dextran , Dibenzyline , 
and Erythropoietin. 
Fetal 
Source Weights 
( treatment ) (gm. ) 
Dibenzyline ( D )  
N o  D 35 . 37 
D 32 . 98 
Erythropoietin (Ep ) 
No Ep 34. 20 
Ep 34 , 1 4 -
Iron Dextran (Fe )  
No Fe 33 , 74 
Fe 34 . 60 
6RBC Hb 
PCV . 
( 1 0 /cmm. ) (gm�/1 00 ·. mi . ) · (%) 
3 , 63 1 1 . 84 . 44 . 70 
3 . 54 1 2 . 2 1 45 , 28 
3 . 62 1 1 . 99 45 . 5 1 
3 , 55 1 2 , 06 44 , 47 
3 , 56 1 1 . 76 44 , 80 
3 , 6 1  1 2 . 29 45 , 1 7  
Dibenzyline by Erythropoietin (D+Ep) 
No D or Ep 33 , 34 3 . 51 1 1 , 44 43 , 89 
D 35 , 06 3 , 73 1 2 . 55 47. 1 2  
�p 37 , 39 3 , 75 1 2 , 25·• ·: 45, 50 
D+Ep 30. 90 · 3 . 35 1 1 , 88 43 . 44 
MCV· . MCH MCHC 
. ( cµ . ) . (µ)lg , ) (%) 
i 23 . 81 .:. 3.2 . 72 26 . 53 
1 28. 64 ··- 34. 69 21. 00 
1 26 .  1 8  33 . 1 9  26 . 40 
1 26 . 27 34 , 21 27 . 1 3  
1 26 . 73 33 . 20 26 , 30 
1 25 , 72 34 , 2 1 27 , 23 
1 25 , 76 32 . 63 26 , 1 2  
1 26 , 60 33 . 75 26 , 68 
1 21 . 86 32 , 81 26 . 95 
1 30, 69 35 , 62 27. 3 1 
I\) 
\0 
Table 3 :  continued. 
Source 
( treatment ) 
Fetal 
Weights 6RBC Hb PCV 
(gm. ) · ( 1 0 /cmm. ) (gm./1 00 ml . ) (%) 
Dibenzyline by Iron Dextran (D+Fe ) 
No D or Fe 33 . 84 3 . 63 1 1 . 66 44 . 03 
D 33 . 64 3 . 49 1 1 , 86 45 , 58 
Fe 36 . 89 3 . 63 1 2 . 02 45 . 36 
D+Fe 32 , 3 1 3 . 59 1 2 , 56 44 . 98 
Erythropoietin by Iron Dextran (Ep+Fe ) 
No Ep or Fe 33 , 40 3 , 66 1 2 . 1 9  46 , 78 
Ep 34 . 08 3 , 46 1 1 , 34 42 , 82 
Fe 34 , 99 3 . 59 1 1 . 80 44 , 23 
Ep+Fe 34 . 21 3 , 64 1 2 , 78 46 , 1 1  
Dibenzyline by Erythropoietin by 
Iron Dextran (D+Ep+Fe ) 
No D ,  Ep , or Fe 29 , 1 4  3 ,  5 1  1 1 . 40 43 , 61 
D 37 , 67 3 , 8 1 2 , 97 49 , 96 
Ep 38, 55 3 . 75 1 1 . 92 44 . 45 
D+Ep 29 , 62 3 . 1 7 1 0 . 76 41 . 1 9  
Fe 37, 5 5  3 ,  5 1  1 1 . 46 44 , 1 8  
D+Fe 32 . 44 3 , 66 1 2 . 1 3  44 . 28 
Ep+Fe 36 , 23 3 , 76 1 2 . 58 46 , 54 
D+Ep+Fe 32 , 1 8  3 , 53 1 2 . 99 45 . 68 
MCV MCH 
( cµ • ) ( µµg • ) 
1 22 . 1 8 32 . 2 1  
1 31 , 28 34 . 1 9  
1 25 . 44 33 . 23 
1 26 , 00 35 . 1 9 
1 28 . 37 33 . 32 
1 �5 . 09 33 . 07 
1 23 , 98 33 . 06 
1 27 , 46 35 , 36 
1 24 . 97 32 , 47 
1 3 1 , 77 34 ,  1 8  
1 1 9 . 39 31 , 95 
1 30, 78 34 . 1 9  
1 26 . 54 32 . 80 
1 2 1 . 41 33 , 32 
1 24 , 34 33 , 67 
1 30 . 59 37 . 05 
MCHC 
(%) 
26 . 54 
26 . 06 
26 . 52 
27 . 94 
26 , 1 1  
26 , 49 
26 . 69 
27 , 77 
26 . 28 
25 , 94 
26 . 81 
26 . 1 7  
25 , 95 
27 , 42 
27 . 09 
28. 46 
DISCUSSION 
Erythropoietin , iron dextran , dibenzyline , or combinations of 
them were administered to doe rabbits in the last trimester of preg­
nancy to study their effect on the hemoglobin system of the does and 
fetuses . 
Although hemogram value differences were not statistically 
significant for the does some treatment mean decreases, relative 
to controls, were consistent with the statistically significant 
increases found for the fetuses .  Decreased mean doe MCH values in 
all groups following treatment and decreased doe MCHC values in all 
groups except for �ron dextran plus dibenzyline and iron · .dextran� 
·plus dibenzyline plus erythropoietin trea�ments occurred. These 
decreases may indicate hemoglobin precursors are transferred to the 
fetuses . Possibly the iron dextran plus dibenzyline and iron dextran 
plus dibenzyline plus erythropoietin treatments increased hemoglobin 
Precursor formation in the does sufficiently to compensate for 
transfers to fetuses .  Placental transfer seemed to take precedence 
over maternal utilization. 
Differences between treated fetunes were statistically signi­
ficant in several parameters .  Analysis of the weight data revealed 
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that the - dibenzyline effect was significant as well as its interaction 
With erythropoietin and iron dextran and the three factor ( dibenzyline, 
erythropoietin , and iron dextran) interaction. A closer look at the 
treatment means indicated that in the absence of either erythropoietin 
or iron dextran , dibenzyline produced an increase in weight . However, 
in the presence of either or both erythropoietin and iron dextran 
a reduction resulted in weight by adding dibenzyline .  The greatest 
weight gain resulted from erythropoietin alone and the least weight 
gain from the control. The main effect and interaction treatment 
means appear in table 3. 
The only significant effect on the red blood cell count was 
the dibenzyline times er,rthropoietin interaction which was highly 
significant. The packed cell volume values showed highly significant 
changes in the dibenzyline times erythropoietin and iron dextran .times 
erythropoietin interactions as well as significant changes in the 
three factor interaction group. Highly significant changes in the 
hemoglobin values 'occurred in the iron dextran times erythropoietin 
and dibenzyline times erythropoietin interactions and in the three 
factor interaction. Iron dextran alone also changed the hemoglobin 
values significantly. Significant changes in the MCV values occurred 
in the two · factor interactions of iron dextran and erythropoietin, 
and iron dextran and dibenzyline. Dibenzyline caused highly signi­
ficant alterations in the MCH values and the iron dextran and 
erythropoietin interaction caused a significant change in MCH. 
Treatments of iron dextran and erythropoietin alone elicited highly 
significant changes in the MCHC values as did the two factor inter­
action of iron dextran and dibenzyline.  Complete analysis of variance 
for the seven parameters studied appear in the appendix table 4. 
The chemicals apparently altered the hemoglobin syte� of 
the treated does and fetuses .  However ,  hemogram valuea are not 
all uniformly changed by treatment with a single chemical or the 
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various combinations of the chemicals . This effect seems consistent 
with results in the literature . Swanson ( 1 33 ) reported that swine 
partial protein-free filtrate ( PPFF) plus iron dextran when adminis­
·tered prepartum to swine seemingly promoted iron transfer and incor­
poration into hemoglobin in one day old piglets .  PPFF seemed to be 
transfered to the fetuses enhancing highest packed cell volume values 
at 49 days of age . Lippert (
a3 ) showed no significant enhancement of 
erythropoiesis employing L-ascorbic acid , iron dextran, and rabbit 
erythropoietin treatments prepartum in doe rabbits. 
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SUMMARY 
Effects of ad.ninistered erythropoietin, dibenzyline, and iron 
dextran upon the hemograms of Dutch Belted doe rabbits and fetuses 
were investigated. Hemoglobin concentration, packed cell volume, 
red blood cell count, mean corpuscular volume, mean corpuscular 
hemoglobin, and mean corpuscular hemoglobin concentration parameters �  
were involved . The experimental animals were maintained on a pelle� 
tized rabbit diet. 
The animals were divided into control and experimental groups. 
The experimental treatments were as follows : iron dextran; erythro­
poietin ; dibenzylil?,e; iron dextran and erythropoietin; dibenzyline 
and erythropoietin ; iron dextran and dibenzyline; and iron dextran, 
dibenzyline, and erythropoietin. Pretreatment doe blood samples were 
taken on day 25 of gestation and posttreatment samples on day 30 of 
gestation, then fetuses were removed by cesarean section and fetal 
blood samples taken. 
Statistical analysis of fetal and doe hematological data was 
performed using analyses of variance. Fetal data showed highly 
significant (P ( . 01 ) increases in hemoglobin for iron dextran admin­
istration. Iron administration possible caused placental transfer 
of hemoglobin precursors. Refer to table 3 for the average main 
eftects and interaction values for iron dextran, dibenzyline, and 
erythropoietin treatments. Significant changes in fetal weight indi­
cated the effect of dibenzyline was to decrease body weight. 
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However , in the absence of either erythropoietin or iron dextran 
dibenzyline caused a weight increase . Doe hematological data showed 
no significant changes , possible indicating preferential transfer 
of hemoglobin precursors . 
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APPENDIX 
Basis 
Weight 
49 
Table 4 :  Analyses of Variance in Control and Experimental 
Fetuses .  
Source 
( treatment ) 
Fe 
Ep 
D 
FexEp 
DxEp 
FexD 
FexDxEp 
Error 
d. f. 
1 
1 
1 
1 
1 
1 
1 
86 
Sum of 
squares 
1 7  . 01 
0.01 
1 3 1 .88 
1 2 . 39 
388 . 51 
1 1 0 . 41 
494 . 58 
1 605 . 08 
Mean squares "F" 
1 7  . 01 NS 
0.01 NS 
1 31 . 88  7 . 07** 
1 2 . 39 NS 
388. 5 1  20 . 82** 
1 1  o . 4 1  5 . 92* 
494. 58 26 . 50** 
1 8. 66 
Red Blood Cell 
Fe 1 0 . 071 0 . 071 NS 
Ep 1 0 . 1 1 7 0 . 1 1 7 NS 
D 1 0 . 1 91 0 . 1 91 NS 
FexEp 1 0 . 379 0 . 379 NS 
DxEp 1 2 . 255 2 . 255 1 3 . 92** 
FexD 1 0 . 06 1 0 . 06 1  NS 
FexDxEp 1 0 . 324 0 . 324 NS 
Error 86 1 3 . 929 0 . 1 62 
Packed Cell Volume 
Fe 1 3 . 1 1  3 . 1 1  NS 
Ep 1 24 . 97 24 . 97 NS 
D 1 7 .83 7 . 83 NS 
FexEp 1 1 96 . 99 1 96 . 99 9 . 91 ** 
DxEp 1 1 6 1 . 23 1 6 1 . 23 8 . 1 1  ** 
FexD 1 21 . 40 2 1 . 40 NS 
FexDxEp 1 1 08 . 33 1 08. 33 5 . 45* 
·Error 86 1 709 . 87 1 9 . 88  
. Table 4 :  continued . 
Basis 
Source 
( treatment)  
Hemoglobin 
Fe 
Ep 
D 
FexEp 
DxEp 
FexD 
FexDxEp 
Error 
MCV 
Fe 
Ep 
D 
FexEp 
DxEp 
FexD 
FexDxEp 
Error 
MCH 
Fe 
Ep 
D 
FexEp 
DxEp 
FexD 
FexDxEp 
Error 
d .  f .  
1 
1 
1 
1 
1 
1 
1 
86 
1 
1 
1 
1 
1 
1 
1 
86 
1 
1 
1 
1 
1 
1 
1 
86 
Sum of 
squares 
6 . 44 
0. 1 1  
3 . 1 9  
1 9 . 40 
1 2 .75 
0 . 67 
8 . 74 
1 09 . 1 4 
23 . 53 
0. 22 
539 . 28 
264 . 92 
368. 39 
420. 90 
66 . 34 
86 1 2 . 77 
23 . 65 
24. 34 
88. 99 
37. 69 
1 6 . 6 1 
0. 01 
7 . 84 
6 1 5 . 69 
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Mean squares "F" 
6 . 44 5 . 32* 
0. 1 1  NS. 
3 . 1 9  NS 
1 9 . 40 1 6 . 03** 
1 2 . 75 1 0 . 54** 
o . 67 NS 
8. 74 7 . 22** 
1 . 21 
23 . 53 NS · .. 
0 . 22 NS 
539 . 28 5 . 38* 
264 . 92 NS 
368. 39 NS 
420. 90 4. 20* 
66 . 34 NS 
1 00. 1 5  
23. 65 NS 
24. 34 NS 
88. 99 1 2 . 43** 
37 . 69 5 . 26* 
1 6 . 6 1 NS 
0 .. 0 1  NS 
7 .84 1 NS 
7. 1 6  
Table 4 :  continued . 
Source 
Basis ( treatment ) •  d. f .  
MCHC 
Fe 
Ep 
D 
FexEp 
DxEp 
FexD 
FexDxEp 
Error 
* P < . 05 ** P < . 01 
NS Not significant 
1 
1 
1 
1 
1 
1 
1 
86 
Sum of 
squares 
1 9 . 95 
1 2 . 34 
5 .00 
2 . 95 
0 . 24 
20 . 98 
0 .05 
1 1 2 . 99 
Mean squares 
1 9 . 95 
1 2 . 34 
5 .00 
2 . 95 
0. 24 
20. 98  
0. 05 
1 . 31 
5 1  
" F" 
1 5 . 23** 
9 . 42** 
NS 
NS 
NS 
1 6 . 02** 
NS 
Table 5 : Hemogram Values of Saline Treated Does and Fetuses. 
Weight RBC Hb PCV 
.lnimal (gm . ) C 1 0
6 
/ cmni. } (gm./1 00m1 . ) (�) 
Doe 1 Initial- - 4 .96 1 1 .a 37 .a 
Doe 1 Final - 4 .31 1 0 . 1 30.0 
Fetus 1 38 2 .35 a . 1 29 .0  
2 .  34 3 . 1 4 9 .7 35 . 5  
3 35 2 . 50 a .4  32.0 
4 33 3 . 28 1 0 . 1 36 .0 
5 32 3 . 32 1 0. 4  37 .0 
Doe 2 Initial- 5 . 44 1 2.a 38.5  
Doe 2 Final - 6 . 37 1 3 .0 40.0  
Fetus 1 22 3 .76 1 2.a 5 1 .0 
2 30 3 . 67 1 1 .4  46 - 5  
3 24 3 .a9 1 2 .6  49 .0 
4 31 3 .73 1 2 .4  48.0 
5 25 3 .77 1 1  .a 45 . 5 
6 26 3 .7a 1 2 .0 47 .0 
7 21 4 .03 1 3 . 3  5 1 .0 
8 26 3 . 98 1 4 . 1 53 .0 
9 31 4 .02 1 2 . 6 50 .0  
;. 
MCV MCH MCHC 
( cµ . ) (µµgm. ) (%) 
76 . 1  23.a 31 . 3  
69 .6 23 .4  33 .7 
1 23 . 4  34 . 5  27 .9 
1 30. 1 30 .9 27 .3  
1 28.0 33 . 6  26 -3  
1 09 .9  30.a 28 . 1  
1 1 1 . 4  31 . :,  28 . 1  
10.a 23 . 5  33.2 
62·.a 20.4  32 . 5  
1 35 .a 34 .0  25 .0 
1 26 -7 30.9 24.4 
1 26 . 1  32 .4 25 .7 
1 28 -9 33. 3  25 .a  
1 20.a 31 . 3  25 .9 
1 24 . 3  31 .7 25 . 5 
1 26 . 6  33. 1 26 . 1  
133 .2  35 .4 26 - 5  
1 24 .4 31 . 3  25 . 2  
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Table 6 :  Hemogram Values of Iron Dextran Treated Does and Fetuses . 
Weight REC lib rov 
Animal (gm . )  ( 1 06/ cmm . )  ( gm ./1 00rnl . )  (%) 
Doe 1 Initial- 6 .32 � 3 .4 . 40 .0 
Doe 1 Final - 4 .48 1 1 .0 34 .0 
Doe 2 Initial- 5 .7a 1 3 . 2  38 .0 
Doe 2 Final - 6 . 1 5  1 3 .8 41 .0 
Fetus 1 34 3 .79 1 2 . 5  45 .0 
2 36 3 , 65 1 2·. 3  4a .o  
3 32 3 .92 1 1  . a  43 .0 
4 35 3 .88 1 2 .0 47 . 5  
5 36 3 . 62 1 2 . 1 46 .0  
Doe 3 Initial- 2 . 1 2  6 .0 18 .8 
Doe 3 Final - 4 . 62 1 0 . 3  31 . 5  
Fetus 1 40 ·2 .80 1 0 . 4  40 .0 
2 39 3 . 24 1 0 . 9  42 .0 
3 38 3 . 57 1 1  . a  45 .0 
4 41 3 . 32 1 1  • 1 42 . 5  
5 40 : 3 . 49 1 0 .7  44 .0 
6 42 3 .31 1 0 . 5  43 .0 
MCV 
( cp.. ) 
63 . 3 
75 . 9  
65 .8 
66 -7 
1 1 8 .7  
1 31 . 5 
1 09 .7 
1 22 . 4  
1 27 . 1  
88-4  
68. 2  
1 42 .9 
1 29 . 6  
1 26 . 1  
1 28.0 
1 26 . 1  
1 29 .9 
MCH l-�CHC 
(ppgm. ) (%} 
21 . 2  33 . 5  
24 .6 32 .4 
22 . 9  34 .7 
22 .4  33 . 5 
33 .0 27 !8 
33 .7 25 . 6  
30 . 1 27 .4 
30.9 25 .3 
33 .4 26 .3 
2s . 3 31 .6 
22 .3  32 .7  
37 . 1 26 .0 
33 . 6  26 .0 
33 . 1 26 . 2  
33 .4 26 . 1  
30 .7 24 .3 
31 .7 24 .4 
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Table 7 :  Hemogram Values of Erythropoietin Treated Does and 
Fetuses.  · · 
Weight RBC Hb PCV 
Animal {gm. ) ( 1 0
6/emm. ) (gm./1 00m1. ) (%) 
Doe 1 Initial- 4.35 1 2.0 35.5  
Doe 1 Final - - 5. 1 9 1 1 . 3 35.0 
Doe 2 Initial.:. 4 .9:, 1 1 .0 :,3.0 
Doe 2 Final - 4 .49 9 .a 32.0 
Fetus 1 34 3 .75 1 1 .3 43.5 
2 35 :, .96 1 2.0 47 .5  
:, 41 :, .62 1 1 .0 42 .0 
4 36 3 . 59 1 1 . 2  42.5  
5 42 4 .25 1 2.,  47 .0 
6 33 3.99 1 1 .6 44 .0 
Doe :, Initial- ·3 .49 9.2 28.0 
Doe 3 Final - 5.42 1 0 .a 35.0 
Fetus 1 40 3 . 1 1  1 2. 6 48.Q 
. 2  38 3.68 1 2. 3  46.0 
3 40 4.01 1 3 .2 47 .0 
4 42 3 .46 1 1 .2 40 .5  
5 43 3 .a1 1 2.4  41 .0 
MCV MCH MCHC 
( cµ. ) (p;igm. ) (%) 
a1 .7 27 .6  33.a 
67 - 5  21 .a 32.3  
74.a 22.3 33.3 
71  .:,  21 .a 3().6  
1 1 6.0 30. 1 26.0 
1 20. 1  30.3  .25.3 
1 1 6.2  30.4 26.2 
1 18.6 31 . 1  26.2 
1 10. 6 2a.9  26. 1 
1 1 0.3 29. 1  26.4 
00.3 26 . 4  32.9 
64-6 1 9 .9  30.a 
1 54 . 3  40 . 5  26.:, 
1 25.2  33 .4 26.7 · 
1 1 7 .2 32 .a 28.0 
1 1 7 . 2  32.4 27.7 
1 07.6 32.4  30. 1 
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Table 8 : Hemogram Values of Dibenzyline Treated Does and 
Fetuses .  
Weight 6RBC Hb PCV 
Animal (gm. ) ( 1 0/cmm. ) (gm./1 00ml . )  {%) 
Doe 1 Initial- 5 .70 1 2 .7 38.8 
Doe 1 Final -
Doe 2 Initial- 5 . 43 1 3 . 3  ,a.a 
Doe 2 Final - 5 .71 1 1 .3 37 .5  
Fetus 1 40 3.46 1 1 . 5 47 .0 
2 38 4.01 1 2 .0 49 .0 
3 42 3 .a9 1 2 . 5  45 .5  
4 40 3.9a 1 3 .0 51 .0 
5 43 3 .00 1 2 .a 50.0 
6 39 3 .66 1 1 .9 48.5 
7 41 3 .a9 12.0 46 -5 
Doe 3 Initial- 4.84 1 1 .0 33.a 
Doe 3 Final - 3.  38 a. 1 24.0 
. Fetus 1 37 3.a2 1 3 .a 50.0 
2 33 4. 1 5  1 3 .7 51 .5  
3 32 3 . 54 1 4 . 6  56 .0 
4 34 3 .73 1 3 .7 51 .0 
5 33 3 .74 1 4. 1  53 . 5  
MCV 
( cµ. ) 
68.0 
70.0 
,, 65 ,7 
1 36 .0 
122 .2 
1 1 7 .0 
128 . 1 
1 31 .9  
1 32 .9  
1 1 9 .a 
69 .7 
: 71 . 1  
1 30.9 
124.2 
1 58-2 
1 36 -7 
1 43 .2 
MCH MCHC 
(ppgm. ) (%) 
22.3 32 .a 
24. 5  35 .0 
· 1 9 .a 30. 1  
33.3  24. 5  
30.0 24 .5  
32. 1  27 , 5  
32.7 25 . 5  
33.a 25 . 6  
32 .6  24 . 5  
30.9 25 .a 
22.7 32 .6  
23 .9 33 . 6  
36 .0 27 . 5  
33 . 1 26 . 6  
41 . 2  26 . 1 
36 .7  26 .9 
37 .a 26 .4 
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Table 9 : Hemogram Values of Iron Dextran and Erythropoietin 
Treated Does and Fetuses. 
Weight RBC Hb PCV 
Animal (gm. )  ( 106/cmm. ) (gm./ 100ml. ) {%) 
Doe 1 Initial-
Doe 1 Final -- � 
Fetus 1 34 
2 38 
3 34 
4 32 
5 34 
6 30 
7 36 
Doe 2 Initial-
Doe 2 Final -
Fetus 1 41 
2 38 
Doe 3 Initial-
Doe 3 Final 
Fetus 1 
2 
3 
4 
-
41  
38 
34 
41 
4 .42 1 0.0 29 .0 
4.75 1 0. 4 30 . 5  
3 .49 1 1 . 6 43 .5  
3 . 59 1 2 . 5  46.0 
3 . 24 1 1 . 5 42.0 
3 . 42 1 2 .4 46 - 5 
3 . 1 a  10 . 7  38 .0 
4 . 1 9  1 3 . 6  50.0  
3 . 20 1 2 . 1 41 .0  
3 . 1 3  9 .0 22.0  
5.56 1 1 .7 ,a.o 
5 .00 1 1 . 6 42 .0 
4 .39 1 2.7 47 .0 
4 .23 9 .7  32 .0 
4 . 38 1 0.a 33 .0 
3 . 46 1 3 .0 49 .0 
4 . 1 5  1 3 .3  50.0  
4 . 1 a  1 3 .7 53 .0 
4 . 60 1 4 .a 57 .0 
MCV MCH MCHC 
( cµ. ) (ppgm. ) (%) 
65. 6  22. 6  34.5 
64-2  21 .9 34. 1  
1 24 .s  33. 3  26.7  
1 28. 1 34.7 27. 1  
1 29 .a  35 . 5  27.4 
1 36 .0 36 . 1  26 . 6  
1 1 9 . 5  33 . 6  28. 2  
1 1 9 . 3  32. 5  27 .2  
1 28. 1 37 .a 29 .5 
70.4  28 .8 40.9 
68.J 21 . 0  -,0.7 
1 1 0 . 5  30. 5  Z'{.6 
1 07 . 1 2a.9 27 .0 
. 75.7  22.9 30.3 
75. 3  24. 5  32 . 6  
1 41 - 6  37 . 6  26 .5 
1 20·. 6  32.2  26 .7 
1 26 .8 32.a 25 .a 
1 24.0 32.2 26 .Q 
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Table 1 0 :  Hemogram Values of Erythropoietin and Dibenzyline 
Treated Does and Fetuses . 
Weight 6 RBC Hb f'CV 
Animal (gm. ) ( 1 0  / cmm . ) (gm./ 1 00ml .  ) (%) 
:noe 1 Initial- 5 . 20 1 2 . 6  36 .8  
Doe 1 Final - 5 . 69 1 2 .0  38.0 
Doe 2 Initial- 5 . 62 1 1 . 3 34.a 
Doe 2 Final - 5 . 55 1 1  .o 35 .0 
Fetus 1 29 3 . 52 1 0.7 42.0 
2 30 3 . 24 1 0.7  42. 5  
3 29 3 .a2 1 1 .a 45 .0 
4 30 3 . 20 1 0 . 4  40 .0 
5 31 3 . 23 1 1 . 3 44 .0 
6 26 3 . 23 1 1 .0 44 .0 
Doe 3 Initial- 5 .31  1 1 . 3 34 .3  
Doe 3 Final - 4 .as 9 .a 31 . 5  
Fetus 1 24 2 . 23 1 0 . 1  37 -0 
2 29 3 .09 1 1 .0 41 . 5 
3 33 2 . 95 1 0 . 1  39 .0 
4 27 3 .00 1 0 . 2  39 . 0 
5 35 3 . 1 1 1 0 .7  40.0 
6 31 3 .47 1 1  . 5  42 . 5  
7 31 3 . 1 1  1 0 . 4  39 .0 
MCV MCH MCHC 
( cp . ) (ppgm . ) (%) 
70 .7 24 . 2  34 . 3  
66 .8 21 . 1  31 . 6 
61 . 9 20 . 1  32 . 5  
63. 1  1 9 .a 31 . 4  
1 1 9 . 3  30 . 4  25 . 5 
1 31 . 4 33 . 1  24 . 2  
1 1 8 .0  30.9  26 .2  
1 25 . 2  32 . 6  26 .0 
1 36 . 4  35 .0 25 .7 
1 36 - 4  34 . 1  25 .0 
64 . 5  2 1 . 3  33 .0 
64 .9  20 . 2  31 . 1  
1 59 .a 43 . 6  27 . 3  
1 34 . 5  35 . 5 26 . 9  
1 32 . 4  34 .3  25 . 9  
1 30 .0  34 .0  26 . 2  
1 28 . 6  34 .4  26 .8 
1 22 .7  33 . 1 21 .0 
1 25 . 4  33 . 4  26 . 7  
57 
Table 1 1' :  Hemogram Values of Iron Dextran and Dibenzyline 
Treated Does and Fetuses . 
Weight RBC Rb PCV 
AnirnaJ (gm , } ( 1 06/cmm. )  {gm ./1oom1 . ) {%) 
Doe 1 Initial- 5 . 1 8  12.5 37.5 
Doe 1 Final --- 6 ,77 1 2 . 9  40.5  
Fetus 1 38 4 .02 11 .8 45_.o 
2 30 4 . 21 13 .0 49 .0 
Doe 2 Initial- 5 .32 11.2 36.Q 
- Doe 2 Final - 5 . 55 10.6  23.0 
Fetus 1 30 3_. 28 12.3 43.5 
2 22 4 . 24 14 . 1 51.0 
3 26 3 .87 13 . 3  49 .0 
4 28 3.a2 12.0 43 .0 
5 30 3. 39 11.0 40.0 
Doe 3 Initial- 4. 63 12 .0 35 .5 
Doe 3 Final - 5 . 42 1 2. 1  ;a-.o 
Fetus 1 46 3. 15 10 .7 38 .5 
2 42 3 .01 1 1 .0 39 . 5  
Mcv� 
( cµ. ) 
72 .4 
59.9 
11 2 . 1  
1 16 .5  
67 .7 - · 41 .4 
1 32 .a  
1 20.3  
1 26.6 
1 12 . 6  
1 18 .0 
76-7  
70. 1 
1 22 .4 
1 31 .4 
MCH MCHC 
(ppgm. ) (") 
24 . 1  33.3 
19.0 31 �9 
29 .4 26-3 
31 .5 26 .5 .. 
21.0 31 .0  
_1 9 . 1  46•l  
37 .6 28 .3  
33 . 2  Z, .6 
34.4 27. 1  
31.4 27.9 
32. 5 27.6 
25.9  33 .a 
22.3 31 . a  
34.0 21 .a 
36 - 4  27 . 7  
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Table 1 2 :  Hemogram Values of Iron Dextran , Dibenzyline , and 
Erythn>poietin Treated Does and Fetuses. 
Weight 
6RB
C Hb PCV 
Animal ·:. (gm. ) ( 1 0  / cmm. ) (gm./1 00ml. ) (%) 
Doe 1 Initial- 4.70 9 .7 33 .0 
Doe 1 Final -
Doe 2 Initial- 5 . 54 1 1  . 6  36 � 5  
Doe 2 Final - 5 . 1 2  1 1  .o 34. 5  
Fetus 1 36 4 .30 1 3 .8 50.0  
2 32 3 . 67 1 2 .9 46 - 5  
3 32 3 .43 1 2 .2  43 . 5 
4 26 2 .81 1 1 .7 43 .0 
5 28 3 .26 1 2 .0 42.0 
6 30 3 . 37 1 3 .0  41 . 5 
7 32 3 . 1 0  1 2 . 6  47 . 5  
8 32 ,3 . 69 1 3 . 2  48. 5  
Do e  3 Initial- 6 .03 1 3 .8 41 �o 
Doe 3 Final - 6 . 53 1 3 .0 40 .0 
Fetus 1 32 3 .98 1 5 . 5  48.0 
2 38 3 . 65 1 3 .0 47 .0 
3 36 3 . 54 1 3 .0  45 .0 
MCV 
( C}l • )  
70 .3  
65 .9 
67 -4  
1 1 6 .4 
1 26 -9  
1 27 .0 
1 53.0 
1 28 .8 
1 23 . 1  
1 53 . 2  
1 3 1 .4 
68.0 
61 . 3  
1 20 . 6  
1 28.8 
1 27 . 2  
MCH MCHC 
{pPlslll- )  (%) 
20.7 29 .4 
20.9 3 1 .a 
21 . 5  3 1 .9 
32.0 27 . 5  
35 .2  -z, .7 
35 . 6  28 .0  
41 .6 27. 2  
36 .8 28. 6  
38 .5  31 . 3 
40. 6  26 . 5  
35 .a 27 . 2  
22.9 33 . 6  
i·
9 32 . 5 
,9  32. 3  
35 . 6  27 .7 
36 .7 2a.9  
